CN104256607A - 一种海参雪莲养生制品 - Google Patents
一种海参雪莲养生制品 Download PDFInfo
- Publication number
- CN104256607A CN104256607A CN201410532596.XA CN201410532596A CN104256607A CN 104256607 A CN104256607 A CN 104256607A CN 201410532596 A CN201410532596 A CN 201410532596A CN 104256607 A CN104256607 A CN 104256607A
- Authority
- CN
- China
- Prior art keywords
- sea cucumber
- parts
- health
- snow lotus
- saussurea involucrata
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 52
- 241000133134 Saussurea Species 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 37
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 17
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 17
- 241001145025 Saussurea involucrata Species 0.000 claims description 27
- 240000002853 Nelumbo nucifera Species 0.000 claims description 25
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 25
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 25
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 21
- 244000194101 Ginkgo biloba Species 0.000 claims description 20
- 230000036541 health Effects 0.000 claims description 18
- 239000003826 tablet Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 240000008415 Lactuca sativa Species 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 235000012045 salad Nutrition 0.000 claims description 5
- 239000007901 soft capsule Substances 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 210000005259 peripheral blood Anatomy 0.000 abstract description 9
- 239000011886 peripheral blood Substances 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract description 2
- 229940068052 ginkgo biloba extract Drugs 0.000 abstract description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 abstract description 2
- 210000002216 heart Anatomy 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000002526 effect on cardiovascular system Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 208000035126 Facies Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010006179 Breast atrophy Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 241000218628 Ginkgo Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229930188089 Holothurin Natural products 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 108700023400 Platelet-activating factor receptors Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010046792 Uterine hypotonus Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- MAWWITJOQDJRJF-ADBICINLSA-M holothurin Chemical compound [Na+].O[C@@H]1[C@@H](OC)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@H]([C@@H]3O)OS([O-])(=O)=O)O[C@@H]3C([C@H]4[C@](C=5[C@H]([C@@]6(CC[C@]7(O)[C@](C)([C@H]8OC(C)(C)CC8)OC(=O)[C@@]76[C@@H](O)C=5)C)CC4)(C)CC3)(C)C)O[C@@H]2C)O)O[C@H](C)[C@H]1O MAWWITJOQDJRJF-ADBICINLSA-M 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000030769 platelet activating factor receptor Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及保健品技术领域,具体地说是一种海参雪莲养生制品,其特征在于由海参、雪莲、银杏叶提取物和甜橙粉组成,其中海参、雪莲、银杏叶提取物及甜橙粉各组分的重量配比为:海参5.0~90.0份,雪莲5.0~90.0份,银杏叶提取物10.0~30.0份,甜橙粉1.0~5.0份,具有提供一种用于增强免疫力、保护心脑血管、改善外周血液循环、降低血清胆固醇、增强体力和抗除疲劳等优点。
Description
技术领域
本发明涉及保健品技术领域,具体地说是一种用于增强免疫力、保护心脑血管、改善外周血液循环、降低血清胆固醇、增强体力和抗除疲劳的海参雪莲养生制品。
背景技术
随着社会的发展和不断进步,人们的生活水平得到提高,但是随之而来的各种社会压力使人们的身体也呈现出各种亚健康问题,体弱、多病、免疫力低下等各种问题甚至影响到工作和学习,因此,人们对健康问题越来越重视,对保健品的需求也越来越大。目前,市场上销售的保健品种类繁多,各有各的功效,但大都含有人造甜味剂、色素、香料、防腐剂等,对人体健康不利,而且现有的保健品存在保健功能单一,保健效果不是十分理想,无法满足人们对健康的需求。
海参,是海味“八珍”之一,与燕窝、鲍鱼、鱼翅齐名,性微寒,味甘、咸,归肺、肾、大肠经,有补肾益精、养血润燥等功效,医学上常用于主治精血亏损;虚弱劳怯;阳痿;梦遗;肠燥便秘;肺虚咳嗽、咯血,肠风便血,外伤出血等,素有“百病之克星”、“长寿之神”、“百补之首”、“补血之神”等美誉,是高蛋白滋补食品,海参的主要有蛋白质、多肽、海参素、粘多糖、脂类等多种营养成分,具有广谱的抗肿瘤作用,抑制癌细胞的生长于转移,对恶性肿瘤的生长、转移具有显著抑制作用,有抗炎、成骨作用,对肝炎患者、结核病、糖尿病、心血管疾病有显著的治疗作用,药用保健价值极高。
雪莲,又称雪莲花、石莲,是美容珍品,性味苦、微苦、温;含有多种生物活性有效成分,其中伞形花内酯具有明显的抗菌、降压镇静、解痉作用,东莨菪素具有祛风、抗炎、止痛、祛痰和抗肿瘤作用,秋水仙碱能抑制癌细胞的增长;雪莲有清热解毒、祛风湿、消肿、止痛功效,对延缓衰老、消除疲劳、神经衰弱、降低胆固醇、调整血压等有显著功效。
银杏叶提取物(Ginkgo Biloba Extract,GBE):香气,味苦,以银杏叶为原料,萃取的有效成分富集的一类产品,具有显著的拮抗PAF受体、抗炎、抗过敏、扩张血管效用,用于治疗记忆丢失、胃部疼痛、痢疾、高血压、精神紧张和呼吸道问题如哮喘,支气管炎和循环不良及其引起的焦虑。
发明内容
本发明的目的是解决上述现有技术的不足,提供一种用于增强免疫力、保护心脑血管、改善外周血液循环、降低血清胆固醇、增强体力和抗除疲劳的海参雪莲养生制品。
本发明解决其技术问题所采用的技术方案是:
一种海参雪莲养生制品,其特征在于由海参、雪莲、银杏叶提取物和甜橙粉组成,其中海参、雪莲、银杏叶提取物及甜橙粉各组分的重量配比为:海参5.0~90.0份,雪莲5.0~90.0份,银杏叶提取物10.0~30.0份,甜橙粉1.0~5.0份,选取上述各组分重量比按照常规方法进行制粒。
本发明所述的一种海参雪莲养生制品,最优选各组分重量配比为:海参50份,雪莲45份,银杏叶提取物15份,甜橙粉5份。
本发明所述的一种海参雪莲养生制品,其特征在于雪莲是由雪莲培养物制备。
本发明所述的一种海参雪莲养生制品,其特征在于制成散剂、颗粒剂、胶囊剂、片剂,优选为片剂、颗粒剂。
本发明所述的一种海参雪莲养生制品,其特征在于片剂制备成糖果压片、咀嚼片、泡腾片。
本发明所述的一种海参雪莲养生制品,其特征在于胶囊剂制备成硬胶囊制剂和软胶囊制剂。
本发明所述的一种海参雪莲养生制品,其特征在于软胶囊制剂是由海参速溶粉、雪莲培养物粉与银杏叶提取物的混合物加入色拉油研磨均匀,混合物与色拉油比例为1:3。
本发明由于采用上述组分,具有提供一种用于增强免疫力、保护心脑血管、改善外周血液循环、降低血清胆固醇、增强体力和抗除疲劳等优点。
具体实施方式
下面对本发明进一步说明:
一种海参雪莲养生制品,其特征在于由海参、雪莲、银杏叶提取物和甜橙粉组成,首先选取新鲜海鲜洗净剪开,出去内脏,置于烘干机中烘干,将烘干完全的海参置于干粉粉碎机中进行粉碎,过100目筛网备用,将雪莲培养物同样进行烘干干燥,超微粉碎机粉碎,备用,称取海参、雪莲、银杏叶提取物及甜橙粉各组分的重量配比为海参50份,雪莲45份,银杏叶提取物15份,混合均匀,加入低醇中制粒,干燥,再加入甜橙粉5份,混合均匀,压片,根据实际需要制成散剂、颗粒剂、胶囊剂、片剂,优选为片剂、颗粒剂,其中软胶囊制剂由海参速溶粉、雪莲培养物粉与银杏叶提取物的混合物加入色拉油按照1:3的比例研磨均匀制成。
对制备好的片剂进行生物碱检测分析,用荧光法测定片剂中的秋水仙碱的含量,试验方法参照文献方法《荧光法测定片剂中的秋水仙碱分析实验室1999,03,74-76》进行检测分析,检测结果表明本发明的海参雪莲组合物制剂的秋水仙碱的含量为1mg/100mg,该含量对人体无副作用。
以下实验表明该发明的一种海参雪莲养生制剂对增强免疫力、保护心脑血管、改善外周血液循环、降低血清胆固醇、增强体力和抗除疲劳有明显的功效。
1. 增强体力和抗除疲劳
选取60只同龄且各种生化指标正常且相同的的雄性小鼠,平均分成四组,每组15只,一组为对照组,三组为实验组,对照组正常喂食日常饲料,实验组分别喂养不同剂量的该发明养生制品,一组100mg/kg低量组,二组组为200mg/kg中量组,三组为600mg/kg高量组,其它喂养条件和环境相同,经一个月后,在相同水温下做游泳耐力实验,结果表明平均游泳持续时间:对照组15分钟,一组低量组38分钟,二组中量组50分钟,三组高量组52分钟,由此可见,各剂量组小鼠游泳时间均比对照组延长,本发明的保健品具有增加体力和增强机体抗疲劳能力。
2. 提高免疫力
选取60只小鼠同龄且各种生化指标正常且相同的小鼠,雌雄各半,平均分为四组,每组15只,一组为对照组,三组为实验组,对照组正常喂食日常饲料,实验组分别喂养不同剂量的该发明养生制品,一组100mg/kg低量组,二组组为200mg/kg中量组,三组为600mg/kg高量组,其它喂养条件和环境相同,经一个月后,每组随机选取10 只小鼠,对小鼠进行无菌取脾,制成单细胞悬液,用RPMI1640 完全培养基调节细胞浓度为3×106/ml,将所得的细胞悬液加入到24 孔细胞培养板中,每孔1mL,每种脾细胞悬液加两孔,另外每孔加入75μL ConA 液,另一孔加入相同量的生理盐水,置37℃ 5%CO2 孵箱中培养72h。培养结束前4h,每孔轻轻吸去上清液0.7mL,加入0.7mL 不含小牛血清的RPMI1640 培养液,同时加入MTT(5mg/ mL)50μL/ 孔,继续培养4h,培养结束后,每孔加入1 mL 酸性异丙醇,吹打混匀,使紫色结晶完全溶解,然后分装到96 孔培养板中,每个孔作3 个平行孔,用酶标仪测定570nm 处的光密度值。对照组光密度值0.102,一组低量组0.352,二组中量组0.334,三组高量组0.368,由此可见,对照组与一组、二组、三组有明显差异,一组、二组、三组之间差异不大;
选取60只小鼠同龄且各种生化指标正常且相同的小鼠,雌雄各半,平均分为四组,每组15只,一组为对照组,三组为实验组,对照组正常喂食日常饲料,实验组分别喂养不同剂量的该发明养生制品,一组100mg/kg低量组,二组组为200mg/kg中量组,三组为600mg/kg高量组,其它喂养条件和环境相同,经一个月后,每组随机选取10 只小鼠,分别称取小鼠免疫器脾脏、胸腺、肝脏,称重,对照组5.632mg/g,一组低量组7.562 mg/g,二组中量组8.053mg/g,三组高量组7.651 mg/g,由此可见,对照组与一组、二组、三组差别很大,一组、二组、三组之间差别不大;
综上所述,本发明对人体免疫力的到明显的提高,具有增强免疫力的功能。
3. 保护心脑血管、改善外周血液循环、降低血清胆固醇
针对保护心脑血管、改善外周血液循环、降低血清胆固醇的功效,发明人寻找30人患有不同程度的心脑血管疾病和血脂偏高,经过服用本发明药剂血压、血脂、血糖、胆固醇有降低现象且趋于正常者21 人,血压、血脂、血糖、胆固醇基本正常者7 人,血压、血脂、血糖、胆固醇有降低现象但效果不理想者2 人,受试者普遍感觉,随着食用时间的增加,不仅血脂、胆固醇降下来了,身体状况也有了很大提高,以前常出现的头昏脑胀、午后易困夜晚却清醒的状况消失了,行动变得更加灵敏,整个人都精神焕发了起来,而且还能明显地感觉到身体免疫能力的提高,即使在感冒流行的季节也没有再患过感冒,由此可见,本发明对人体保护心脑血管、改善外周血液循环、降低血清胆固醇有显著疗效。
4.对本发明养生制品进行毒理学实验
选取60只小鼠同龄且各种生化指标正常且相同的小鼠,雌雄各半,平均分为四组,每组15只,一组为对照组,三组为实验组,对照组正常喂食日常饲料,实验组分别喂养不同剂量的该发明养生制品,一组100mg/kg低量组,二组组为200mg/kg中量组,三组为600mg/kg高量组,其它喂养条件和环境相同,经一个月后,四组大鼠均未出现毒性反应,发育良好,肉眼外观及主要脏器未见异常,外周血象及血清ALT、BUN 与对照组比较无病理性改变,病理报告心、肝、脾、肺、肾、胃等均未有意义的改变,因此,经病理证实,该发明对动物无毒性表现。
实施例1
海参粉20份,雪莲培养物粉70份,银杏叶提取物15份,甜橙粉5份。
实施例2
海参粉60份,雪莲培养物粉15份,银杏叶提取物25份,甜橙粉5份。
实施例3
海参粉50份,雪莲培养物粉50份,银杏叶提取物20份,甜橙粉5份。
实施例4
海参粉30份,雪莲培养物粉25份,银杏叶提取物25份,甜橙粉5份。
实施例5
海参粉80份,雪莲培养物粉85份,银杏叶提取物15份,甜橙粉5份。
人群试食结果
1. 跟踪45例患者,此45例患者,免疫力低,天气稍有变化即感冒,平
均1-2 个月患感冒一次,每天睡前服用本发明养生制品,服用2 个月后,免疫力提高,能抵抗天气的变化,患感冒次数明显减少。
2.许某,山东人,由于工作压力增大,常常失眠多梦,免疫力下降,浑身无力,经服用本发明的海参雪莲养生制剂后,面色明显红润,抵抗力提高,有活力。
3.蔡某,山东人,女,情绪波动、失眠、记忆力减退、月经紊乱、性欲减退、乳房萎缩、皮肤变得粗糙晦暗、弹性减退、毛孔粗大、皱纹加深。经服用本发明所述的海参雪莲养生制品一个月后,睡眠质量好,睡眠深,记忆力增加、月经正常皮肤红润,有光泽,皮肤有弹性,皱纹减少。
4.胡某,山东人,高血脂患者,经服用本发明所述的海参雪莲养生制品二个月后,检查,血粘度达到正常值。
5. 王某,男,56 岁,患有高血脂、高血压、高血糖6 年,2010 年检查,总胆固醇值为8.1mmol/L,连续服用经服用本发明所述的海参雪莲养生制品,总胆固醇值降为6.9mmol/L。
由此可见,经服用本发明所述的海参雪莲养生制品,对增强免疫力、保护心脑血管、改善外周血液循环、降低血清胆固醇、增强体力和抗除疲劳有明显的功效。
Claims (8)
1.一种海参雪莲养生制品,其特征在于由海参、雪莲、银杏叶提取物和甜橙粉组成,其中海参、雪莲、银杏叶提取物及甜橙粉各组分的重量配比为:海参5.0~90.0份,雪莲5.0~90.0份,银杏叶提取物10.0~30.0份,甜橙粉1.0~5.0份,选取上述各组分重量比按照常规方法进行制粒。
2.根据权利要求1所述的一种海参雪莲养生制品,最优选各组分重量配比为:海参50份,雪莲45份,银杏叶提取物15份,甜橙粉5份。
3.根据权利要求1所述的一种海参雪莲养生制品,其特征在于雪莲是由雪莲培养物制备。
4. 根据权利要求1所述的一种海参雪莲养生制品,其特征在于制成散剂、颗粒剂、胶囊剂、片剂,优选为片剂、颗粒剂。
5. 根据权利要求4所述的一种海参雪莲养生制品,其特征在于片剂制备成糖果压片、咀嚼片、泡腾片。
6.根据权利要求4所述的一种海参雪莲养生制品,其特征在于胶囊剂制备成硬胶囊制剂和软胶囊制剂。
7. 根据权利要求4或6所述的一种海参雪莲养生制品,其特征在于软胶囊制剂是由海参速溶粉、雪莲培养物粉与银杏叶提取物的混合物加入色拉油研磨均匀,混合物与色拉油比例为1:3。
8. 根据权利要求1所述的一种海参雪莲养生制品,其特征在于在制备增强免疫力保健品中应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410532596.XA CN104256607A (zh) | 2014-10-11 | 2014-10-11 | 一种海参雪莲养生制品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410532596.XA CN104256607A (zh) | 2014-10-11 | 2014-10-11 | 一种海参雪莲养生制品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104256607A true CN104256607A (zh) | 2015-01-07 |
Family
ID=52148292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410532596.XA Pending CN104256607A (zh) | 2014-10-11 | 2014-10-11 | 一种海参雪莲养生制品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104256607A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105053451A (zh) * | 2015-08-04 | 2015-11-18 | 大连棒棰岛海产股份有限公司 | 含有海参及雪莲成分的糖果制品 |
CN105999159A (zh) * | 2016-06-27 | 2016-10-12 | 深圳太太药业有限公司 | 一种黑糖雪莲组合物及其制备方法 |
CN109497451A (zh) * | 2017-09-15 | 2019-03-22 | 大连长生岛集团有限公司 | 海参阿胶片 |
CN114128820A (zh) * | 2020-09-04 | 2022-03-04 | 天津星宇航天生物科技有限公司 | 一种提高航天员身体机能的营养制剂和制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101073432A (zh) * | 2006-05-16 | 2007-11-21 | 尚玉芝 | 一种雪莲银杏保健茶及其生产方法 |
CN103610065A (zh) * | 2013-12-11 | 2014-03-05 | 威海力元海洋生物科技有限公司 | 一种海参玛咖组合物及其制备方法 |
-
2014
- 2014-10-11 CN CN201410532596.XA patent/CN104256607A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101073432A (zh) * | 2006-05-16 | 2007-11-21 | 尚玉芝 | 一种雪莲银杏保健茶及其生产方法 |
CN103610065A (zh) * | 2013-12-11 | 2014-03-05 | 威海力元海洋生物科技有限公司 | 一种海参玛咖组合物及其制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105053451A (zh) * | 2015-08-04 | 2015-11-18 | 大连棒棰岛海产股份有限公司 | 含有海参及雪莲成分的糖果制品 |
CN105999159A (zh) * | 2016-06-27 | 2016-10-12 | 深圳太太药业有限公司 | 一种黑糖雪莲组合物及其制备方法 |
CN105999159B (zh) * | 2016-06-27 | 2020-03-24 | 深圳太太药业有限公司 | 一种黑糖雪莲组合物及其制备方法 |
CN109497451A (zh) * | 2017-09-15 | 2019-03-22 | 大连长生岛集团有限公司 | 海参阿胶片 |
CN114128820A (zh) * | 2020-09-04 | 2022-03-04 | 天津星宇航天生物科技有限公司 | 一种提高航天员身体机能的营养制剂和制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101136090B1 (ko) | 기능성 식품 및 이의 제조방법 | |
CN105595224A (zh) | 一种海参盐藻葡聚糖硒制剂及制备工艺 | |
CN104257817A (zh) | 一种用于清肠洗肠的中药制剂 | |
CN103859379A (zh) | 一种有助于改善记忆的养生保健食品配方及其制备方法 | |
CN105166544A (zh) | 一种猪配合饲料及其制备方法 | |
CN104256607A (zh) | 一种海参雪莲养生制品 | |
CN104667135A (zh) | 一种药物组合物、保健品及制备方法 | |
CN104352542A (zh) | 一种海参雪莲的组合物制剂及其制备方法 | |
KR20170142756A (ko) | 굼벵이를 포함하는 간 및 혈액순환 개선용 조성물 및 그 제조방법 | |
CN105596843A (zh) | 一种治疗脑血栓的药物组合物及其制备方法 | |
CN105028995A (zh) | 一种配合狗粮及其制备方法 | |
CN108186899A (zh) | 一种治疗肿瘤的中药组合物及其制备方法与应用 | |
CN105535495B (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN105079494A (zh) | 一种降血糖的铁皮石斛胶囊及其制备方法 | |
CN105639497A (zh) | 一种海参火腿肠的配方及其加工工艺 | |
CN108245531B (zh) | 一种改善胃肠道功能、防治便秘的组合物 | |
CN109223886A (zh) | 用于健脾止泻的中药组合物及其制备方法和用途 | |
KR20150078613A (ko) | 침향 및 해양심층수를 유효성분으로 함유하는 항알러지용 조성물 | |
CN105560444B (zh) | 一种用于治疗牦牛胃肠炎的藏药组合物及其制备方法和应用 | |
CN104286243A (zh) | 一种富硒养心茶及其生产方法 | |
CN110063977B (zh) | 一种党参、沙棘复合冲剂及其应用 | |
KR101391647B1 (ko) | 항비만 조성물 | |
CN104667109A (zh) | 一种药物组合物、保健品及制备方法 | |
KR20170032140A (ko) | 줄풀 추출물을 포함하는 국수 제조방법 | |
CN101342331A (zh) | 治疗肺炎和上呼吸道感染的中药喷剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150107 |